Figure 3.
Kaplan–Meier estimates of radiographic progression-free survival (A), and rate of PSA progression (B) according to sarcopenic status. Censored data are marked at each line. PSA, prostate-specific antigen.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.